Clinical study published in Journal of Medicinal Food (Korean Society of Food Science and Nutrition) 2013 Jun;16(6):564-8. doi: 10.1089/jmf.2013.2751.
SALCITAL (500 mg/day) showed no adverse effects in patients with prediabetes and mild to moderate hyperlipidemia throughout the study duration. The physical examination and clinical laboratory investigations performed on day 0 and week 6 in SALCITAL treated groups were found to be within normal limits.